Showing results (101-110 of 130) with videos related to
Sort By:
Pageof 13
Investigational New Drugs|October 10, 2017
Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results : A phase I clinical trialDana B Cardin, Laura W Goff, Emily Chan, et al.Magnetic Resonance Imaging|August 20, 2013
Early assessment of breast cancer response to neoadjuvant chemotherapy by semi-quantitative analysis of high-temporal resolution DCE-MRI: preliminary resultsRichard G Abramson, Xia Li, Tamarya Lea Hoyt, et al.International Journal of Environmental Research and Public Health|August 7, 2021
Feasibility and Efficacy of the "FUNPALs Playgroup" Intervention to Improve Toddler Dietary and Activity Behaviors: A Pilot Randomized Controlled TrialAliye B Cepni, Ashley Taylor, Christine Crumbley, et al.Tomography (Ann Arbor, Mich.)|January 21, 2017
QIN DAWG Validation of Gradient Nonlinearity Bias Correction Workflow for Quantitative Diffusion-Weighted Imaging in Multicenter TrialsDariya I Malyarenko, Lisa J Wilmes, Lori R Arlinghaus, et al.Journal of Medical Imaging (Bellingham, Wash.)|January 12, 2018
Combining multiparametric MRI with receptor information to optimize prediction of pathologic response to neoadjuvant therapy in breast cancer: preliminary resultsHakmook Kang, Allison Hainline, Lori R Arlinghaus, et al.Magnetic Resonance in Medicine|September 16, 2020
MRI-cytometry: Mapping nonparametric cell size distributions using diffusion MRIJunzhong Xu, Xiaoyu Jiang, Sean P Devan, et al.Magnetic Resonance in Medicine|November 26, 2019
Magnetic resonance imaging of mean cell size in human breast tumorsJunzhong Xu, Xiaoyu Jiang, Hua Li, et al.Oncogene|July 30, 2008
Lipocalin 2 is required for BCR-ABL-induced tumorigenesisX Leng, H Lin, T Ding, et al.Breast Cancer (Dove Medical Press)|November 17, 2012
Current and emerging quantitative magnetic resonance imaging methods for assessing and predicting the response of breast cancer to neoadjuvant therapyRichard G Abramson, Lori R Arlinghaus, Jared A Weis, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 24, 2016
Phase I trial of vorinostat added to chemoradiation with capecitabine in pancreatic cancerEmily Chan, Lori R Arlinghaus, Dana B Cardin, et al.Pageof 13